Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2018 Filed Feb 21, 2018 22:20 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 933 | $18.25 | $17,027.25 |
DisclosureSEC source: 0000784199-18-000020 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,703 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:20 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 569 | $18.25 | $10,384.25 |
DisclosureSEC source: 0000784199-18-000020 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,636 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:26 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
Tax withholdingCommon Stock | 1,183 | $18.25 | $21,589.75 |
DisclosureSEC source: 0000784199-18-000026 · certent-form4.xml · nonDerivative · entry 1 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,117 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 4,591 | $18.25 | $83,785.75 |
DisclosureSEC source: 0000784199-18-000024 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,809 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 3,049 | $18.25 | $55,644.25 |
DisclosureSEC source: 0000784199-18-000024 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,400 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 1,413 | $18.25 | $25,787.25 |
DisclosureSEC source: 0000784199-18-000022 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,361 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 1,375 | $18.25 | $25,093.75 |
DisclosureSEC source: 0000784199-18-000022 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,774 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:18 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 1,041 | $18.25 | $18,998.25 |
DisclosureSEC source: 0000784199-18-000018 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,817 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:18 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 836 | $18.25 | $15,257.00 |
DisclosureSEC source: 0000784199-18-000018 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,858 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:16 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 1,183 | $18.25 | $21,589.75 |
DisclosureSEC source: 0000784199-18-000016 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,708 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:15 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 795 | $18.25 | $14,508.75 |
DisclosureSEC source: 0000784199-18-000014 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,073 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:15 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 726 | $18.25 | $13,249.50 |
DisclosureSEC source: 0000784199-18-000014 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,868 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 31,333 | $17.10 Strike: $5.12 | $535,794.30 |
DisclosureSEC source: 0000784199-18-000012 · certent-form4.xml · derivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,333 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/23/2012 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionCommon Stock | 31,333 | $5.12 | $160,424.96 |
DisclosureSEC source: 0000784199-18-000012 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/23/2012 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 9,381 | $17.10 | $160,415.10 |
DisclosureSEC source: 0000784199-18-000012 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,261 F1 · shares: Payment of exercise by delivering shares in accordance to Rule 16b-3. Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:49 UTC |
Saurini Sherry MVP, Quality
|
GrantESPP · Derivative | 191 | $16.24 Strike: $16.24 | $3,100.89 |
DisclosureSEC source: 0000784199-18-000147 · certent-form4.xml · derivative · entry 2 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191 Underlying: Common Stock · 191 shares Expires 2018-06-30 Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:49 UTC |
Saurini Sherry MVP, Quality
|
Exercise / conversionCommon Stock | 191 | $16.24 | $3,100.89 |
DisclosureSEC source: 0000784199-18-000147 · certent-form4.xml · nonDerivative · entry 1 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:47 UTC |
McDermid James MSVP, CHRO
|
GrantESPP · Derivative | 1,179 | $16.24 Strike: $16.24 | $19,141.07 |
DisclosureSEC source: 0000784199-18-000145 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,179 Underlying: Common Stock · 1,179 shares Expires 2018-06-30 Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:47 UTC |
McDermid James MSVP, CHRO
|
Exercise / conversionCommon Stock | 1,179 | $16.24 | $19,141.07 |
DisclosureSEC source: 0000784199-18-000145 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:43 UTC |
Davis John ESenior VP, Global Sales
|
GrantESPP · Derivative | 1,308 | $16.24 Strike: $16.24 | $21,235.38 |
DisclosureSEC source: 0000784199-18-000141 · certent-form4.xml · derivative · entry 4 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 Underlying: Common Stock · 1,308 shares Expires 2018-06-30 Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:43 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 1,308 | $16.24 | $21,235.38 |
DisclosureSEC source: 0000784199-18-000141 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:46 UTC |
Holloway Jean FVP, General Counsel
|
GrantESPP · Derivative | 861 | $16.24 Strike: $16.24 | $13,978.34 |
DisclosureSEC source: 0000784199-18-000143 · certent-form4.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 861 Underlying: Common Stock · 861 shares Expires 2018-06-30 Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:46 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 861 | $16.24 | $13,978.34 |
DisclosureSEC source: 0000784199-18-000143 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC |
McDermid James MSVP, CHRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 821 | $16.28 Strike: $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · derivative · entry 3 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 821 shares Expires 2017-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC |
McDermid James MSVP, CHRO
|
GrantStock Option (Right to Buy) · Derivative | 821 | $16.28 Strike: $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821 Underlying: Common Stock · 821 shares Expires 2017-12-31 Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC |
McDermid James MSVP, CHRO
|
Exercise / conversionCommon Stock | 821 | $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:46 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 567 | $16.28 Strike: $16.28 | $9,229.34 |
DisclosureSEC source: 0000784199-18-000004 · certent-form5.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 567 shares Expires 2017-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:46 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 567 | $16.28 Strike: $16.28 | $9,229.34 |
DisclosureSEC source: 0000784199-18-000004 · certent-form5.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567 Underlying: Common Stock · 567 shares Expires 2017-12-31 Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:46 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 567 | $16.28 | $9,229.34 |
DisclosureSEC source: 0000784199-18-000004 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:30 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 1,000 | $20.00 | $20,000.00 |
DisclosureSEC source: 0000784199-17-000105 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,849 F1 · kind: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the price of $20 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.12 | $0.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · derivative · entry 6 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/15/2014 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.76 | $0.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · derivative · entry 5 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
SaleCommon Stock | 10,000 | $19.63 | $196,250.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · nonDerivative · entry 4 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,135 F2 · price: Reflects weighted average price. Range was $19.625 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionCommon Stock | 10,000 | $6.12 | $61,200.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · nonDerivative · entry 3 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/15/2014 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
SaleCommon Stock | 10,000 | $19.63 | $196,250.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · nonDerivative · entry 2 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,135 F2 · price: Reflects weighted average price. Range was $19.625 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:17 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionCommon Stock | 10,000 | $5.76 | $57,600.00 |
DisclosureSEC source: 0000784199-17-000103 · certent-form4.xml · nonDerivative · entry 1 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,143 | $18.57 Strike: $5.12 | $559,888.14 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · derivative · entry 8 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,143 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 30,143 | $18.57 | $559,888.14 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · nonDerivative · entry 4 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,149 F3 · price: Reflects weighted average price. Range was $18.50 to $18.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 30,143 | $5.12 | $154,332.16 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · nonDerivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2012). Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,190 | $19.00 Strike: $5.12 | $630,550.26 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · derivative · entry 7 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,143 Underlying: Common Stock · 33,190 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 33,190 | $19.00 | $630,550.26 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,149 F2 · price: Reflects weighted average price. Range was $18.95 to $19.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:47 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 33,190 | $5.12 | $169,932.80 |
DisclosureSEC source: 0000784199-17-000101 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2012). Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:45 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000099 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,205 F2 · shares: 1500 shares were gifted by the reporting person to a charity Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:45 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 4,000 | $19.00 | $76,000.00 |
DisclosureSEC source: 0000784199-17-000099 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,705 F1 · price: Reflects weighted average price. Range was $19 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 22:22 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 1,000 | $19.03 | $19,030.00 |
DisclosureSEC source: 0000784199-17-000096 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,849 F1 · price: Reflects the average price of $19.03 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:49 UTC |
Benson JamesDirector
|
SaleCommon Stock | 2,000 | $22.80 | $45,600.00 |
DisclosureSEC source: 0000784199-17-000090 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,086 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the price of $22.80 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:43 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 81,950 | $21.97 | $1,800,679.16 |
DisclosureSEC source: 0000784199-17-000084 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,449 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. F2 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F4 · price: Reflects weighted average price. Range of prices were between $21.90 to $22.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 21:43 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 43,050 | $22.09 | $951,060.60 |
DisclosureSEC source: 0000784199-17-000084 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,399 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. F2 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F3 · price: Reflects weighted average price. Range of prices were between $21.85 to $22.45. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 21:42 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 1,000 | $22.00 | $22,000.00 |
DisclosureSEC source: 0000784199-17-000082 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,849 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the price of $22 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 21:02 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 4,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000068 · certent-form4.xml · nonDerivative · entry 2 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned indirectly by Spouse in a Revocable Trust Disclosed balance after: 40,667 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.